How AstraZeneca Is Playing Its Cancer Cards To Become An $80 ... Japan, the U.K. and the U.S. each year, Dave Fredrickson, executive vice president of AstraZeneca's oncology business unit, ...

We expect AstraZeneca AZN to beat expectations when it reports second-quarter 2023 results on Jul 28. In the last reported quarter, the company delivered an earnings surprise of 11.63%.

AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca-us.com . 3245502 04/16 ...

AstraZeneca works with IBM to unlock the power of cognitive digitization for business value ... Yet, it’s worth noting what’s on the business card for Mark Clare (pictured, left).

In collaboration with AstraZeneca and Genpact, the company’s business process outsourcing partner, Trintech implemented its Certification solution to manage reconciliations of AstraZeneca’s ...

AstraZeneca's New-York listed ADR rose 2.6% shortly after the open; shares in the drugmaker sold off Monday after it reported mixed results in a trial for an experimental cancer drug.

London-listed AstraZeneca shares fell more than 5% on Tuesday after results from the company's lung cancer trials showed that its experimental precision drug did not significantly improve overall ...